SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-051121
Filing Date
2022-02-24
Accepted
2022-02-24 07:47:27
Documents
6
Effectiveness Date
2022-02-24

Document Format Files

Seq Description Document Type Size
1 S-8 d106955ds8.htm S-8 39463
2 EX-5.1 d106955dex51.htm EX-5.1 8255
3 EX-23.1 d106955dex231.htm EX-23.1 1545
4 EX-FILING FEES d106955dexfilingfees.htm EX-FILING FEES 16939
5 GRAPHIC g106955g0223084311462.jpg GRAPHIC 1649
6 GRAPHIC g106955g81n65.jpg GRAPHIC 7315
  Complete submission text file 0001193125-22-051121.txt   79812
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262948 | Film No.: 22666574
SIC: 2834 Pharmaceutical Preparations